NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol. 2017;23(2):103-108.   Published online 2017 May 10     DOI: https://doi.org/10.3350/cmh.2017.0103
Citations to this article as recorded by Crossref logo
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Yan-Xiao Ji, Zan Huang, Xia Yang, Xiaozhan Wang, Ling-Ping Zhao, Pi-Xiao Wang, Xiao-Jing Zhang, Michele Alves-Bezerra, Lin Cai, Peng Zhang, Yue-Xin Lu, Lan Bai, Mao-Mao Gao, Huan Zhao, Song Tian, Yong Wang, Zhi-Xiang Huang, Xue-Yong Zhu, Yan Zhang, Jun Go
Nature Medicine.2018; 24(2): 213.     CrossRef
Prevention and management of gastroesophageal varices
Yeon Seok Seo
Clinical and Molecular Hepatology.2018; 24(1): 20.     CrossRef
Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action
Eleonora Scorletti, Christopher D. Byrne
Molecular Aspects of Medicine.2018; 64: 135.     CrossRef
NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson
Current HIV/AIDS Reports.2018; 15(3): 212.     CrossRef
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction
Lucienne Juillerat-Jeanneret, John-David Aubert, Josip Mikulic, Dela Golshayan
Journal of Medicinal Chemistry.2018; 61(22): 9811.     CrossRef
Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases
Francesca Bonomini, Elisa Borsani, Gaia Favero, Luigi Rodella, Rita Rezzani
Nutrients.2018; 10(9): 1135.     CrossRef
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
Amedeo Lonardo, Simonetta Lugari, Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Mauro Maurantonio
Acta Diabetologica.2018;[Epub]     CrossRef